SDC1 and colitis: The protective effect of syndecan-1 extracellular domain circulating in the blood has been confirmed during research on mice lacking sCD138; when subjected to an experimental colitis, they have exhibited significantly increased mortality, impaired mucous membrane regeneration, and extended inflammatory cell recruitment.